Analysts Predict A Surge In PainReform Ltd (NASDAQ: PRFX)?

CTK Stock

PainReform Ltd (NASDAQ:PRFX) shares, rose in value on Wednesday, November 20, with price down by -25.71% to the previous day’s close as strong demand from buyers drove the stock to $1.04.

Actively observing the price movement in the last trading, the stock closed the session at $1.40, falling within a range of $0.9721 and $1.15. The value of beta (5-year monthly) was 0.555. Referring to stock’s 52-week performance, its high was $20.16, and the low was $0.43. On the whole, PRFX has fluctuated by 28.40% over the past month.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

With the market capitalization of PainReform Ltd currently standing at about $2.32 million, investors are eagerly awaiting this quarter’s results, scheduled for in December.

Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PRFX’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the price of PRFX currently trading nearly 66.85% and 57.09% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 61.57, while the 7-day volatility ratio is showing 27.91% which for the 30-day chart, stands at 16.62%. Furthermore, PainReform Ltd (PRFX)’s beta value is 0.98, and its average true range (ATR) is 0.18.

A comparison of PainReform Ltd (PRFX) with its peers suggests the former has fared considerably weaker in the market. PRFX showed an intraday change of -25.71% in last session, and over the past year, it shrunk by -91.38%%.

Data on historical trading for PainReform Ltd (NASDAQ:PRFX) indicates that the trading volumes over the past 10 days have averaged 19.66 and over the past 3 months, they’ve averaged 3.51 million. According to company’s latest data on outstanding shares, there are 2.23 million shares outstanding.

Nearly 5.13% of PainReform Ltd’s shares belong to company insiders and institutional investors own 8.02% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.12 million shares as on 2024-10-31, resulting in a short ratio of 0.38. According to the data, the short interest in PainReform Ltd (PRFX) stood at 558.00 of shares outstanding as of 2024-10-31; the number of short shares registered in 2024-09-30 reached 57559.0. The stock has fallen by -93.70% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PRFX stock heading into the next quarter.

Most Popular